Rear View: the best of NBR
Susan Wood looks at the best of NBR this week including continuing analysis of Xero's NZX delisting and the companies continuing to experience global growth.
Susan Wood looks at the best of NBR this week including continuing analysis of Xero's NZX delisting and the companies continuing to experience global growth.
Susan Wood looks at the best of NBR this week including continuing analysis of Xero's NZX delisting and the companies new and old continuing to experience global growth (subscribe at nbr.co.nz/subscribe or claim a 30-day trial via nbr.co.nz/free).
• Aussie analyst jacks up Xero target price, NZ broker finds ‘blemish’ – Chris Keall
• NZX left no stone unturned to keep Xero – Tim Hunter
• Peters’ lawyer accuses journalists of ‘charading’ as pension case proceeds – Victoria Young
• Why FishFish has floundered while BurgerBurger beefs up – Fiona Rotherham
• Live from the Hive – Susan Wood
• Douglas Pharma aims to double revenue by 2025 – Fiona Rotherham
• Timely lands $7m investment - Chris Keall
• Rakon returns to profit but doubts cast over sustainability – Calida Smylie
• Pushpay boss accelerates US listing timetable – but says will stay on NZX, too – Chris Keall